Indian Pharmaceutical Industry Based on SWOT Analysis (2023): A Review
Abstract
Indian pharmaceutical companies are developing at a very fast pace and contributing to the national economy. India accounts for 10% of world production and ranks third in the world in terms of volume. COVID has changed the whole perspective of “Pharmaceuticals” globally and a SWOT analysis in these newer times is a tool for a company’s strengths, weaknesses, opportunities and threats. There are many pharmaceutical companies in India. Among them, few are the giants of the market and technically more enlightened. Few firms are diminutive as well as conventional. Some companies dominate the whole medicine market in India, as a result, they must contend with fierce rivalry in the drugs sector. Any industry's SWOT analysis examines the key variables that could affect the sector and have an impact on how businesses operate. This review article aims to figure out realizable path to overcome the weakness and threats of company and to make use of the strength and opportunity optimally.
References
Patel PV. Drug regulation in India: SWOT analysis. Int J Drug Regul Aff. 2018; 3 (3): 21–27. Available at https://www.ijdra.com/index.php/journal/article/view/168 [Accessed on March 27, 2023].
Nayak N. Competition impediments in the pharmaceutical sector in India. Background paper prepared for the National Competition Policy, Indian Institute of Corporate Affairs. 2011.
CDSCO asks health ministry to release ₹ 1600 cr under 12th Plan for strengthening regulatory apparatus. Pharmabiz.com. 2015 Available at from: http://www.pharmabiz.com/NewsDetails.aspx?aid=87574&sid=1 [Accessed on March 27, 2023].
India’s drug regulation system in a total shambles. India Today. 2012 Available at https://www.indiatoday.in/india/north/story/drug-regulation-system-in-india-is-in-a-shambles- dcgi-101563-2012-05-08 [Accessed on March 27, 2023].
World Economic Outlook, October 2010: Recovery, Risk, and Rebalancing. IMF. 2010. Available at from: https://www.imf.org/en/Publications/WEO/Issues/2016/12/31/World- Economic-Outlook-October-2010-Recovery-Risk-and-Rebalancing-
#:~:text=World%20Economic%20Outlook%2C%20October%202010%3A%20Recovery% 2C%20Risk%2C%20and%20Rebalancing,- Publication%20Date%3A&text=Summary%3A,and%20have%20continued%20high%20unemplo yment [Accessed on March 27, 2023].
Shastri A. Comprehensive SWOT analysis of Dr. Reddy’s Laboratories – An Indian multinational pharmaceutical company. IIDE 2022. Available atfrom: https://iide.co/case-studies/swot-analysis- of-dr-reddys-laboratories/ [Accessed on March 27, 2023].
Nandy M. Strategic Pharmaceutical Marketing Management in Growth Markets. New York: Taylor & Francis; 2023.
Pal S, Biswas B, Gupta R, Kumar A, Gupta S. Exploring the factors that affect user experience in mobile-health applications: a text-mining and machine-learning approach. J Business Res. 2023; 156: 113484.
